🇺🇸 Neuromultivit in United States

67 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. C-Reactive Protein Increased — 8 reports (11.94%)
  2. Aggression — 7 reports (10.45%)
  3. Anaemia — 7 reports (10.45%)
  4. Communication Disorder — 7 reports (10.45%)
  5. Pyrexia — 7 reports (10.45%)
  6. Somnolence — 7 reports (10.45%)
  7. Agitation — 6 reports (8.96%)
  8. Diarrhoea — 6 reports (8.96%)
  9. Emotional Disorder — 6 reports (8.96%)
  10. Fall — 6 reports (8.96%)

Source database →

Other Neuroscience approved in United States

Frequently asked questions

Is Neuromultivit approved in United States?

Neuromultivit does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Neuromultivit in United States?

Bausch Health Americas, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.